<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>zidovudine</title><link>http://www.unboundmedicine.com/medline/ebm/research/zidovudine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Reversed phase HPLC determination of zidovudine in rat plasma and its pharmacokinetics after a single intranasal dose administration.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915744/full_citation/Reversed_phase_HPLC_determination_of_zidovudine_in_rat_plasma_and_its_pharmacokinetics_after_a_single_intranasal_dose_administration_</link><description>Mainardes RM, Palmira D Gremião M <br/><span class="title">Reversed phase HPLC determination of zidovudine in rat plasma and its pharmacokinetics after a single intranasal dose administration. [Journal Article]</span><br/><span class="source" title="Biological research">Biol Res 2009; 42(3):357-64.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915744/abstract/Reversed_phase_HPLC_determination_of_zidovudine_in_rat_plasma_and_its_pharmacokinetics_after_a_single_intranasal_dose_administration_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915744/full_citation/Reversed_phase_HPLC_determination_of_zidovudine_in_rat_plasma_and_its_pharmacokinetics_after_a_single_intranasal_dose_administration_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19915744/Reversed_phase_HPLC_determination_of_zidovudine_in_rat_plasma_and_its_pharmacokinetics_after_a_single_intranasal_dose_administration_">Find Related Articles</a> </description></item><item><title>In vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915582/full_citation/In_vivo_assessment_of_mitochondrial_toxicity_of_metacavir_in_Rhesus_monkeys_after_three_months_of_intravenous_administration_</link><description>Zeng W, Cheng AC, Chen ZL, et al. <br/><span class="title">In vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration. [JOURNAL ARTICLE]</span><br/><span class="source" title="Acta pharmacologica Sinica">Acta Pharmacol Sin 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915582/abstract/In_vivo_assessment_of_mitochondrial_toxicity_of_metacavir_in_Rhesus_monkeys_after_three_months_of_intravenous_administration_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915582/full_citation/In_vivo_assessment_of_mitochondrial_toxicity_of_metacavir_in_Rhesus_monkeys_after_three_months_of_intravenous_administration_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19915582/In_vivo_assessment_of_mitochondrial_toxicity_of_metacavir_in_Rhesus_monkeys_after_three_months_of_intravenous_administration_">Find Related Articles</a> </description></item><item><title>Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915448/full_citation/Postpartum_antiretroviral_drug_resistance_in_HIV_1_infected_women_receiving_pregnancy_limited_antiretroviral_therapy_</link><description>Paredes R, Cheng I, Kuritzkes DR, et al. <br/><span class="title">Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="AIDS (London, England)">AIDS 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915448/abstract/Postpartum_antiretroviral_drug_resistance_in_HIV_1_infected_women_receiving_pregnancy_limited_antiretroviral_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915448/full_citation/Postpartum_antiretroviral_drug_resistance_in_HIV_1_infected_women_receiving_pregnancy_limited_antiretroviral_therapy_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0269-9370%26amp;volume=%26amp;issue=%26amp;spage=">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19915448/Postpartum_antiretroviral_drug_resistance_in_HIV_1_infected_women_receiving_pregnancy_limited_antiretroviral_therapy_">Find Related Articles</a> </description></item><item><title>Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911963/full_citation/Viremia_Resuppression_and_Time_to_Resistance_in_Human_Immunodeficiency_Virus__HIV__Subtype_C_during_First_Line_Antiretroviral_Therapy_in_South_Africa_</link><description>Hoffmann CJ, Charalambous S, Sim J, et al. <br/><span class="title">Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911963/abstract/Viremia_Resuppression_and_Time_to_Resistance_in_Human_Immunodeficiency_Virus__HIV__Subtype_C_during_First_Line_Antiretroviral_Therapy_in_South_Africa_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911963/full_citation/Viremia_Resuppression_and_Time_to_Resistance_in_Human_Immunodeficiency_Virus__HIV__Subtype_C_during_First_Line_Antiretroviral_Therapy_in_South_Africa_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911963/Viremia_Resuppression_and_Time_to_Resistance_in_Human_Immunodeficiency_Virus__HIV__Subtype_C_during_First_Line_Antiretroviral_Therapy_in_South_Africa_">Find Related Articles</a> </description></item><item><title>Lipodystrophy and metabolic complications of highly active antiretroviral therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907933/full_citation/Lipodystrophy_and_metabolic_complications_of_highly_active_antiretroviral_therapy_</link><description>Parakh A, Dubey AP, Kumar A, et al. <br/><span class="title">Lipodystrophy and metabolic complications of highly active antiretroviral therapy. [Journal Article]</span><br/><span class="source" title="Indian journal of pediatrics">Indian J Pediatr 2009 Oct; 76(10):1017-21.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907933/abstract/Lipodystrophy_and_metabolic_complications_of_highly_active_antiretroviral_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907933/full_citation/Lipodystrophy_and_metabolic_complications_of_highly_active_antiretroviral_therapy_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19907933/Lipodystrophy_and_metabolic_complications_of_highly_active_antiretroviral_therapy_">Find Related Articles</a> </description></item><item><title>Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_</link><description>Vaz P, Chaix ML, Jani I, et al. <br/><span class="title">Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Pediatric infectious disease journal">Pediatr Infect Dis J 2009 Nov 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/abstract/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_">Full Citation</a></description></item><item><title>The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19905037/full_citation/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_</link><description>Marseille E, Kahn JG, Pitter C, et al. <br/><span class="title">The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. [Journal Article]</span><br/><span class="source" title="Applied health economics and health policy">Appl Health Econ Health Policy 2009; 7(4):229-43.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19905037/abstract/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19905037/full_citation/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_">Full Citation</a></description></item><item><title>[Treatment of chronic hepatitis C in HIV-infected patients]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19375043/full_citation/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]</link><description>Bani-Sadr F <br/><span class="title">[Treatment of chronic hepatitis C in HIV-infected patients] [English Abstract, Journal Article]</span><br/><span class="source" title="Gastroentérologie clinique et biologique">Gastroenterol Clin Biol 2009 Mar.:S97-S103.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19375043/abstract/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19375043/full_citation/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19375043/[Treatment_of_chronic_hepatitis_C_in_HIV_infected_patients]">Find Related Articles</a> </description></item><item><title>Insulin Sensitivity in Multiple Pathways is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19898246/full_citation/Insulin_Sensitivity_in_Multiple_Pathways_is_Differently_Affected_During_Zidovudine/Lamivudine_Containing_Compared_With_NRTI_Sparing_Combination_Antiretroviral_Therapy_</link><description>van Vonderen MG, Blümer RM, Hassink EA, et al. <br/><span class="title">Insulin Sensitivity in Multiple Pathways is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19898246/abstract/Insulin_Sensitivity_in_Multiple_Pathways_is_Differently_Affected_During_Zidovudine/Lamivudine_Containing_Compared_With_NRTI_Sparing_Combination_Antiretroviral_Therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19898246/full_citation/Insulin_Sensitivity_in_Multiple_Pathways_is_Differently_Affected_During_Zidovudine/Lamivudine_Containing_Compared_With_NRTI_Sparing_Combination_Antiretroviral_Therapy_">Full Citation</a></description></item><item><title>Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19895691/full_citation/Antiretroviral_activity_of_the_aminothiol_WR1065_against_Human_Immunodeficiency_virus__HIV_1__in_vitro_and_Simian_Immunodeficiency_virus__SIV__ex_vivo_</link><description>Poirier MC, Olivero OA, Hardy AW, et al. <br/><span class="title">Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo. [JOURNAL ARTICLE]</span><br/><span class="source" title="AIDS research and therapy">AIDS Res Ther 2009 Nov 6; 6(1):24.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19895691/abstract/Antiretroviral_activity_of_the_aminothiol_WR1065_against_Human_Immunodeficiency_virus__HIV_1__in_vitro_and_Simian_Immunodeficiency_virus__SIV__ex_vivo_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19895691/full_citation/Antiretroviral_activity_of_the_aminothiol_WR1065_against_Human_Immunodeficiency_virus__HIV_1__in_vitro_and_Simian_Immunodeficiency_virus__SIV__ex_vivo_">Full Citation</a></description></item></channel></rss>